Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

Johnson & Johnson (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
138.72 -0.14    -0.10%
- Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US4781601046 
WKN:  853260
  • Volume: 3,640
  • Bid/Ask: 138.66 / 138.84
  • Day's Range: 138.62 - 139.12
J&J 138.72 -0.14 -0.10%

Johnson & Johnson Co Company Profile

 
Get an in-depth profile of Johnson & Johnson, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

152700

Equity Type

ORD

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Contact Information

Address One Johnson & Johnson Plaza
New Brunswick, 08933
United States
Phone 732 524 0400
Fax -

Top Executives

Name Age Since Title
Joaquin Duato 60 2011 CEO & Chairman
Paula A. Johnson 63 2023 Independent Director
Mark B. McClellan 59 2013 Independent Director
Jennifer A. Doudna 59 2018 Independent Director
Mary C. Beckerle 68 2015 Independent Director
Mark Alan Weinberger 61 2019 Independent Director
D. Scott Davis 71 2014 Independent Director
Darius E. Adamczyk 57 2022 Independent Director
Hubert Joly 64 2019 Independent Director
Nadja Y. West 62 2020 Independent Director
Paula A. Johnson 63 2023 Independent Director
Eugene A. Woods 59 2023 Independent Director
Anne M. Mulcahy 72 2009 Independent Director
Marillyn A. Hewson 70 2019 Lead Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Comments

Write your thoughts about Johnson & Johnson Co
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Maria Kenny
Maria Kenny Jun 11, 2024 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JNJ bought SWAV accretive to earnings long-term. SWAV was small cap darling in 2023 Lithotripsy breakthroughs. Not sure if analysts will like affect near term on EPS but good add to portfolio.
San Marina
San Marina Jun 07, 2024 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is historically bullet proof company with steady stock price growth. Will hit $170 in few months
Dimas Mardjono
Dimasm Apr 29, 2024 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shite & shite
Zaza Zaza
Zaza Zaza Apr 29, 2024 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go to sleep
jean Bendaci
jean Bendaci Dec 28, 2023 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very good fruit gummies.
Dec 11, 2023 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
On its way to $130
Dimas Mardjono
Dimasm Nov 15, 2023 11:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
let's go
Oct 02, 2023 12:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jnj seems like enjoy being sold. i thought that healthcare stocks are the best in bear market.
biblios anto
biblios anto Sep 04, 2023 1:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is happen with JNJ ? Does anyone know?
kiven Geldon
kiven Geldon Aug 24, 2023 7:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Safe haven trade about to technically bounce soon. The canary in the big coal mine.
Kennet Sam
Kennet Sam Aug 23, 2023 2:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good ferry good
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email